Target Name: NPM1P22
NCBI ID: G390411
Other Name(s): nucleophosmin 1 pseudogene 22 | Nucleophosmin 1 pseudogene 22

NPM1P22: A Potential Drug Target and Biomarker

NPM1P22, also known as nucleophosmin 1 pseudogene 22, is a protein that is expressed in various tissues and cells throughout the body. It is a key component of the nucleosome, which is the basic unit of chromatin that contains the genetic instructions for the development and function of all living organisms.

Recent studies have identified NPM1P22 as a potential drug target and biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. This is because NPM1P22 has been shown to play a role in the regulation of cell division and metabolism, which is often disrupted in these diseases.

One of the key mechanisms by which NPM1P22 is involved in these processes is through its role in the maintenance of the chromatin structure. NPM1P22 is a transcription factor that helps to recruit other proteins to the chromatin to form the nucleosome. This process is critical for the regulation of gene expression, and is often disrupted in cancer cells, where the nucleus is often hyperplastic and difficult to control.

In addition to its role in chromatin regulation, NPM1P22 has also been shown to be involved in the regulation of cell migration and the development of tissues. It has been shown to play a role in the development of tissues such as the brain and heart, and has been shown to be involved in the regulation of cell division and differentiation in these tissues.

Given its involvement in these processes, NPM1P22 has potential as a drug target for a variety of diseases. For example, NPM1P22 has been shown to be involved in the development of neurodegenerative diseases, such as Alzheimer's and Parkinson's disease. It has also been shown to be involved in the development of cancer, and has been shown to promote the growth and survival of cancer cells.

In addition to its potential as a drug target, NPM1P22 has also been identified as a potential biomarker for a variety of diseases. For example, NPM1P22 has been shown to be elevated in the blood of people with certain types of cancer, and has been used as a biomarker for the diagnosis of these diseases. It has also been shown to be elevated in the urine of people with neurodegenerative diseases, and has been used as a biomarker for the diagnosis of these diseases.

Overall, NPM1P22 is a protein that has the potential to be a drug target and biomarker for a variety of diseases. Further research is needed to fully understand its role in these processes and to develop effective treatments.

Protein Name: Nucleophosmin 1 Pseudogene 22

More Common Targets

NPM1P25 | NPM1P27 | NPM1P28 | NPM1P35 | NPM1P42 | NPM1P47 | NPM1P48 | NPM2 | NPM3 | NPNT | NPPA | NPPA-AS1 | NPPB | NPPC | NPR1 | NPR2 | NPR3 | NPRL2 | NPRL3 | NPS | NPSR1 | NPSR1-AS1 | NPTN | NPTN-IT1 | NPTX1 | NPTX2 | NPTXR | NPVF | NPW | NPY | NPY1R | NPY2R | NPY4R | NPY4R2 | NPY5R | NPY6R | NQO1 | NQO2 | NR0B1 | NR0B2 | NR1D1 | NR1D2 | NR1H2 | NR1H3 | NR1H4 | NR1I2 | NR1I3 | NR2C1 | NR2C2 | NR2C2AP | NR2E1 | NR2E3 | NR2F1 | NR2F1-AS1 | NR2F2 | NR2F2-AS1 | NR2F6 | NR3C1 | NR3C2 | NR4A1 | NR4A2 | NR4A3 | NR5A1 | NR5A2 | NR6A1 | NRAD1 | NRADDP | NRAP | NRARP | NRAS | NRAV | NRBF2 | NRBF2P4 | NRBP1 | NRBP2 | NRCAM | NRDC | NRDE2 | NREP | NRF1 | NRG1 | NRG2 | NRG3 | NRG4 | NRGN | NRIP1 | NRIP2 | NRIP3 | NRIP3-DT | NRIR | NRK | NRL | NRM | NRN1 | NRN1L | NRON | NRP1 | NRP2 | NRROS | NRSN1